A former AstraZeneca Pharmaceuticals LP sales specialist can proceed with her claim that the company unlawfully fired her after refusing Covid-19 vaccination, a federal district court said.

The vaccine has been credited with saving millions of lives - GETTY IMAGES EUROPE/MATTHEW HORWOOD The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

AstraZeneca (NASDAQ:AZN) has declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” What Happened: The company began the withdrawal process on ...

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines ...

May 8 (UPI) --British-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally. The company has admitted it could cause rare blood clots but said the vaccine was ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

In this March 3, 2021, file photo, a package of the AstraZeneca Covid-19 vaccine is shown in the state of Brandenburg where the first coronavirus vaccinations are given in doctors' surgeries, in ...

The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...

CHICAGO -- For the first time, many people in the United States who want to protect themselves against the flu this respiratory virus season can order a vaccine to give themselves at home. AstraZeneca ...

BOSTON & ST. LOUIS--(BUSINESS WIRE)--Omniose, a preclinical biotechnology company, today announced an exclusive collaboration agreement with AstraZeneca to research potential vaccines for bacterial ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...